Navigation Links
Stereotaxis Announces Global Initial Training Site at University of Chicago
Date:12/30/2010

ST. LOUIS, Dec. 30, 2010 /PRNewswire/ -- Stereotaxis, Inc. (Nasdaq: STXS) announced today that starting in 2011, Stereotaxis will utilize the Remote Magnetic Navigation System in the electrophysiology (EP) lab at the University of Chicago Medical Center to train clinicians planning to install Stereotaxis at their own centers.

With adoption of Stereotaxis' Remote Magnetic Navigation System growing steadily, there is significant new demand for training with the system from clinicians worldwide. The Heart Rhythm Center at the University of Chicago (UCMC) is a world-leader in the care of patients with irregular heartbeats.

"The Heart Rhythm Center at the University of Chicago is one of the busiest university-based interventional programs in the greater Chicago area, providing the latest in diagnostic and treatment modalities," said Dr. Martin Burke, Acting Chief of Cardiology. "With Stereotaxis, we have the ability to care for people with the most complex irregular heartbeats."

This arrangement between UCMC and Stereotaxis creates a unique opportunity for electrophysiologists and other interventionalists who need training in magnetic navigation. UCMC will dedicate its Stereotaxis lab for training with phantom models for discrete periods, giving the Stereotaxis Clinical Training Directors the ability to provide guidance free from the distractions that are common when clinicians engage in training in their own facilities.

"Our experience shows that a well-trained EP clinical team adopts magnetic navigation much more rapidly in the year following the system's installation," said Michael P. Kaminski, President and Chief Executive Officer of Stereotaxis. "So we are focused on developing our clinical training programs as a key business strategy. With our recently launched Odyssey Interventional Network, the Global Initial Training Site demonstrates Stereotaxis' commitment to enhancing the standard of interventional care with innovative education and training solutions. We are excited and grateful to be working with Dr. Burke on this important venture."

About Stereotaxis

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Niobe® Remote Magnetic Navigation System is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, shorter procedure time and reduced x-ray exposure.

Stereotaxis' Odyssey™ portfolio of products provides an innovative enterprise solution for integrating, recording and networking interventional lab information within hospitals and around the world. Odyssey™ Vision integrates data for magnetic and standard interventional labs, enhancing the physician workflow through a consolidated display of multiple systems and eliminating the challenge of interacting simultaneously with many separate diagnostic systems. Odyssey™ Enterprise Cinema then captures a complete record of synchronized procedure data that can be viewed live or from a comprehensive archive of cases performed.  Odyssey™ then enables hospitals to efficiently share live and recorded clinical data anywhere around the world to maximize referrals and promote collaboration.

The core components of the Stereotaxis systems have received regulatory clearance in the U.S., Europe, Canada and elsewhere. For more information, please visit www.stereotaxis.com and www.odysseyexperience.com.

This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company's products in the marketplace, the effect of global  economic conditions on the ability and willingness of customers to purchase our systems and the timing of such purchases, competitive factors, changes resulting from the recently enacted healthcare reform in the U.S., including changes in government reimbursement procedures, dependence upon third-party vendors, timing of regulatory approvals, and other risks discussed in the Company's periodic and other filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release. There can be no assurance that the Company will recognize revenue related to its purchase orders and other commitments in any particular period or at all because some of these purchase orders and other commitments are subject to contingencies that are outside of the Company's control. In addition, these orders and commitments may be revised, modified, delayed or canceled, either by their express terms, as a result of negotiations, or by overall project changes or delays.


'/>"/>
SOURCE Stereotaxis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Stereotaxis Completes $40 Million Credit Facility
2. Stereotaxis Announces Public Offering of Common Stock
3. Stereotaxis Receives Commitment to Increase and Extend Credit Facility
4. Stereotaxis Awarded $1.5 Million in Grants under the Qualifying Therapeutic Discovery Project Program
5. Stereotaxis Reports Third Quarter Financial Results
6. Stereotaxis Appoints Industry Veteran as Head of EMEA Sales and Operations
7. Stereotaxis Announces Third Quarter 2010 Earnings Release Date and Conference Call
8. Stereotaxis Launches the Odyssey Interventional Network for Superior Online Cardiovascular Education and Training
9. Stereotaxis Announces Third Quarter 2010 Capital Orders of $12.2 Million, Up 94 Percent Year-to-Year
10. Stereotaxis to Present at the JMP Securities Healthcare Conference
11. Stereotaxis Achieves Intellectual Property Milestone With 100th U.S. Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... Scope of the Report The report titled "Global ... (2016-2020)", provides an in-depth analysis of the global continence ... The market also provides an in-depth analysis of intermittent ... regional analysis of continence care market, including the following ... Europe and Rest of the World. The ...
(Date:1/23/2017)... The Pharmacy Technician Certification Board (PTCB) ... planned 2020 accredited education requirement for pharmacy technicians ... 2013 that the requirement would take effect in ... program changes designed to keep pace with the ... "We have determined that additional deliberation ...
(Date:1/23/2017)... YORK , Jan. 23, 2017 Consolidated ... Partners and Driving the Stability Testing Outsourcing Market ... market addresses market sizing, emerging trends, and technologies, and ... market. The base year is 2015 and forecasts are ... is expected to grow at a CAGR of 9.4% ...
Breaking Medicine Technology:
(Date:1/24/2017)... ... January 23, 2017 , ... The TouchPoint Solution, ... who entered metrics into the product’s app. The data replicates and validates ... that within just 30 seconds of using Buzzies, people experienced a 74 percent ...
(Date:1/24/2017)... ... January 23, 2017 , ... ... a new plugin that allows sleep centers to automatically connect and initialize all ... a thin client browser plugin is quickly installed on first use and then ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... week at a new domain address. Alpine Springs Rehabilitation & Recovery Center’s new ... debuted a new logo along with its redesigned and retooled website. The treatment ...
(Date:1/23/2017)... Palo Alto, CA (PRWEB) , ... ... ... Translations, a provider of translation and localization services for life science companies, ... testing and inspection organization, TÜV SÜD America. ISO 17100 is the globally ...
(Date:1/23/2017)... ... January 23, 2017 , ... DMG ... Innovations with Ed Begley, Jr., scheduled to broadcast Saturday, January 28, 2017 at ... was founded in 2008 to address the limitations of fatigue monitoring technologies within ...
Breaking Medicine News(10 mins):